Law Offices of Howard G. Smith announces that it is investigating potential claims against the board of directors of Global Med Technologies, Inc. (“Global Med” or the “Company”) (OTC:GLOB.OB) related to the proposed acquisition of Global Med by Haemonetics Corporation (“Haemonetics”). The proposed transaction is valued at approximately $60 million.

Under the terms of the definitive agreement entered into by the parties, Haemonetics will commence a tender offer to purchase all outstanding shares of Global Med common stock at $1.22 per share and preferred stock at approximately $1,694 per share. The investigation concerns possible breaches of fiduciary duty and other violations of law related to approval of the transaction by the Global Med board of directors.

If you own shares of Global Med, if you have information or would like to learn more about these claims, or if you wish to discuss these matters or have any questions concerning this announcement or your rights or interests with respect to these matters, please contact Howard G. Smith, Esquire, of Law Offices of Howard G. Smith, 3070 Bristol Pike, Suite 112, Bensalem, Pennsylvania 19020 by telephone at (215) 638-4847, Toll Free at (888) 638-4847, or by email to howardsmith@howardsmithlaw.com, or visit our website at http://www.howardsmithlaw.com.

Copyright Business Wire 2010